Botanical wellness for responsible adults Free shipping on eligible orders
Skip to Content
Education center

Questions before conclusions.

Our goal is not to tell people what to think. Our goal is to help people understand what current evidence says, where evidence is strong, where it is weak, and where important questions remain unanswered.

What is medical cannabis?

Medical cannabis refers to cannabis-derived products used under medical supervision for specific health conditions. Research into cannabinoids such as THC and CBD has expanded significantly over the past two decades, but evidence quality varies considerably between conditions.

What does current research show?

1. Chronic pain

Several systematic reviews have found that non-inhaled cannabis-based medicines may provide modest improvements in chronic pain, physical function, and sleep for some patients. However, benefits are generally moderate rather than dramatic, and responses vary between individuals.

Evidence status: moderate but mixed.

2. Chemotherapy-related nausea

Cannabinoid medicines have demonstrated usefulness in reducing nausea and vomiting associated with chemotherapy in some patients when conventional treatments are insufficient.

Evidence status: moderate.

3. Multiple sclerosis symptoms

Some studies have reported improvement in muscle spasticity and related symptoms in people with multiple sclerosis.

Evidence status: moderate but variable.

4. Anxiety, PTSD, depression, and mental health conditions

The largest reviews available have found limited evidence that cannabis-based medicines provide lasting benefits for most mental health conditions, including anxiety disorders, PTSD, psychotic disorders, and substance-use disorders. Researchers continue to investigate whether specific cannabinoids, doses, or patient groups may benefit.

Evidence status: currently limited and inconclusive.

5. Sleep

Some studies report mild improvements in sleep quality. Evidence quality remains variable and additional research is required.

Evidence status: limited to moderate.

What does the science not yet know?

  • Which patients benefit most.
  • Long-term outcomes across different populations.
  • Optimal cannabinoid combinations.
  • Ideal dosing strategies.
  • Comparative effectiveness versus existing therapies.

Risks and considerations

Research has also identified potential risks, including:

  • Impaired attention and coordination.
  • Dependency in some users.
  • Increased risk of adverse psychiatric effects in susceptible individuals.
  • Potential interactions with other medications.

Benefits and risks should always be evaluated with a qualified healthcare professional.

Our position

Kushiva does not ask people to accept claims without evidence. We encourage: Observe. Question. Verify. Update. Repeat.

Choice is Human. AI Shows Options. Evidence Decides.

Important disclaimer

The information provided on this website is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making healthcare decisions.

Sources

  • National Academies of Sciences, Engineering, and Medicine (2017) — The Health Effects of Cannabis and Cannabinoids.
  • The Lancet Psychiatry Review (2026).
  • Systematic Review of Cannabinoids for Medical Use.
  • Benefits and Harms of Medical Cannabis: Scoping Review of Systematic Reviews.
Explore Kushiva Shop the full range
Shop now